The Bcl-2 family: roles in cell survival and oncogenesis

被引:1223
作者
Cory, S [1 ]
Huang, DCS [1 ]
Adams, JM [1 ]
机构
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
关键词
apoptosis; caspases; oncogenesis; mouse models; therapeutics;
D O I
10.1038/sj.onc.1207102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apoptosis, the cell-suicide programme executed by caspases, is critical for maintaining tissue homeostasis, and impaired apoptosis is now recognized to be a key step in tumorigenesis. Whether a cell should live or die is largely determined by the Bcl-2 family of anti- and proapoptotic regulators. These proteins respond to cues from various forms of intracellular stress, such as DNA damage or cytokine deprivation, and interact with opposing family members to determine whether or not the caspase proteolytic cascade should be unleashed. This review summarizes current views of how these proteins sense stress, interact with their relatives, perturb organelles such as the mitochondrion and endoplasmic reticulum and govern pathways to caspase activation. It briefly explores how family members influence cell-cycle entry and outlines the evidence for their involvement in tumour development, both as oncoproteins and tumour suppressors. Finally, it discusses the promise of novel anticancer therapeutics that target these vital regulators.
引用
收藏
页码:8590 / 8607
页数:18
相关论文
共 309 条
  • [11] ASKEW DS, 1991, ONCOGENE, V6, P1915
  • [12] Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs
    Baell, JB
    Huang, DCS
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) : 851 - 863
  • [13] CLONING THE CHROMOSOMAL BREAKPOINT OF T(14-18) HUMAN LYMPHOMAS - CLUSTERING AROUND JH ON CHROMOSOME-14 AND NEAR A TRANSCRIPTIONAL UNIT ON 18
    BAKHSHI, A
    JENSEN, JP
    GOLDMAN, P
    WRIGHT, JJ
    MCBRIDE, OW
    EPSTEIN, AL
    KORSMEYER, SJ
    [J]. CELL, 1985, 41 (03) : 899 - 906
  • [14] Banerjee D, 2001, Curr Opin Investig Drugs, V2, P574
  • [15] Senescence: a companion in chemotherapy?
    Berns, A
    [J]. CANCER CELL, 2002, 1 (04) : 309 - 311
  • [16] APOPTOTIC CELL-DEATH INDUCED BY C-MYC IS INHIBITED BY BCL-2
    BISSONNETTE, RP
    ECHEVERRI, F
    MAHBOUBI, A
    GREEN, DR
    [J]. NATURE, 1992, 359 (6395) : 552 - 554
  • [17] The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
    Borner, C
    [J]. MOLECULAR IMMUNOLOGY, 2003, 39 (11) : 615 - 647
  • [18] Diminished cell proliferation associated with the death-protective activity of Bcl-2
    Borner, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 12695 - 12698
  • [19] Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist bim
    Bouillet, P
    Cory, S
    Zhang, LC
    Strasser, A
    Adams, JM
    [J]. DEVELOPMENTAL CELL, 2001, 1 (05) : 645 - 653
  • [20] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
    Bouillet, P
    Metcalf, D
    Huang, DCS
    Tarlinton, DM
    Kay, TWH
    Köntgen, F
    Adams, JM
    Strasser, A
    [J]. SCIENCE, 1999, 286 (5445) : 1735 - 1738